Plain-English translation of NCT00001971 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at the National Institute of Diabetes and Digestive and Kidney Diseases are building a large collection of blood, tissue, and genetic samples from people with various types of liver disease. The goal is to better understand how liver diseases develop, progress, and respond to treatment—and whether certain genes play a role in who gets sick and who recovers well.
Right now, doctors don't fully understand why some people develop liver disease and others don't, or why the same disease affects different people so differently. By studying genetic material and medical information from many patients over time, researchers hope to discover new clues that could eventually lead to better treatments and prevention strategies.
You likely qualify if…
You likely don't qualify if…
If you have liver disease, you will visit the clinic for routine medical evaluation and follow-up visits over time. During these visits, doctors will collect blood samples, and possibly samples of saliva, urine, stool, or tissue if a liver biopsy is already planned as part of your care. If you are a healthy volunteer, you will have one visit to give a blood sample for genetic comparison. All samples are stored in a repository and used for future research studies on liver disease.
AI-generated summary from trial data · Aug 19, 2026 · Not medical advice
United States